Author

Hanyu Zhang

h-index 4 View on Semantic Scholar

We have 2 of 6 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A disproportionality analysis of adverse event reports for givinostat in the FDA adverse event reporting system (FAERS) database

Thrombocytopenia and hypertriglyceridemia are identified as the most prominent safety signals for givinostat, with platelet count decreased showing a statistically significant difference in serious proportion and a lower serious proportion than the overall baseline.

Lin Chen, Han-Yu Zhang, Yun-Long Wang et al. · Frontiers in Pharmacology · 0 citations

Review Open access Jul 2026

Photothermal therapy triggering organelle stress and metabolic reprogramming to potentiate antitumor immunity

It is proposed that PTT interferes with tumor metabolism through organelle stress and synergizes with exogenous drugs to enhance metabolic perturbation, thereby eliciting a potent antitumor immune response.

Lin Chen, Hanyu Zhang, Yunlong Wang et al. · Frontiers in Immunology · 0 citations